Value-Based Healthcare Services Market

Report ID : 1421 | Published : 2022-10-30 | Pages: 189 | Format: PDF/EXCEL

The market size of the global value-based healthcare services market in 2021 is valued at 5.14 billion and is predicted to reach 26.74 billion by the year 2030 at an 20.36% CAGR during the forecast period.

Value-based healthcare refers to a business model in which service providers, including hospitals, are paid according to their patients' effectiveness, efficiency, cost, and health outcomes. Intense supplier competition and growing pressure to lower costs and enhance treatment have shifted from volume-based to value-based healthcare. Value-based healthcare benefits everyone more, including patients, providers, payers, suppliers, and society. It focuses on assisting patients in promptly recovering and preventing chronic diseases from improving health at lower costs. High patient satisfaction benefits suppliers in the form of more effective care. There have been many quick advancements in the healthcare sector since the advent of digital technology, which supports the growth of the market for value-based healthcare services. Due to increased investment by corporate and governmental organizations, there have been several quick improvements in healthcare following the introduction of digital technology. These changes have led to the market for value-based healthcare services expanding.

Furthermore, market participants have more attractive opportunities as chronic diseases like diabetes and cancer become increasingly widespread in developing countries. However, balancing two payment methods and two types of reimbursement is expected to limit the market growth. But it's projected that the lack of Internet access and essential healthcare facilities in some parts of emerging countries will limit the global market for value-based healthcare services throughout the projection period.

Market Segmentation:

The value-based healthcare services market is segmented by model, deployment type, platform and industry vertical. Based on the model, the market is segmented into accountable care organizations, patient-centred medical homes, pay for performance and bundled payments. Based on the deployment type, the market is segmented into cloud and on-premises. Based on the platform, the market is segmented into standalone and integrated. Based on the industry vertical, the market is segmented into providers (hospitals, clinics, others) and payers (insurance companies, government, others).

Based on the model, the patient-centred medical home category is accounted as a significant contributor to the value-based healthcare services market.

The patient-centred medical home category dominated the market in 2021. Cost transparency is one of the critical developments that will improve the market for value-based healthcare services. By exposing their pricing structure, healthcare systems are assisting patients in better understanding what they are paying for, fostering more patient-health system trust. Patients will grasp the financial implications if they are informed of invoices before they get them. By giving patients clear information about costs, healthcare systems may gain their trust and become more motivated to provide affordable, high-quality care. Through cost transparency, patients can compare options and select the healthcare system that is most appropriate for them. Among the models now on the market, the patient-centred medical home (PCMH) will see a little larger demand.

The cloud category witnessed growth at a rapid rate.

The cloud category dominated the market in 2021. Medical professionals and patients can instantly and easily access clinical data using cloud and wireless technologies in the healthcare IT industry. Given that they are practical and affordable communication channels between healthcare providers and patients, wireless and cloud technologies are predicted to expand quickly in the healthcare industry.

The North American value-based healthcare services market holds a signification revenue share.

The North American value-based healthcare services market is expected to register the highest market share due to increased patient demand for more easily accessible, functional, and affordable care. The established healthcare infrastructure and hub for significant industry players in the region significantly impact the market for value-based healthcare services. Because clinicians understand how early disease identification can lead to high patient satisfaction and enhanced treatment efficiency, value-based healthcare services are commonly used in the United States. In addition, Asia Pacific is projected to increase in the global value-based healthcare services market due to the region's improved healthcare infrastructure, increased awareness, and improved population perspective. The rise in the commercial need for providers to satisfy those three patient requests contributes to the expansion. Additionally, the market in the Asia Pacific is projected to grow because of a rise in artificial intelligence and machine learning technologies that support telemedicine capabilities in the region.

Competitive Landscape

Key players in the value-based healthcare services market are Deloitte Touche Tohmatsu Limited, Siemens Healthcare GmbH, Veritas Technologies LLC, Genpact, McKesson Corporation, NXGN Management LLC, 3M and Koninklijke Philips N.V.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Value-Based Healthcare Services Market Snapshot

Chapter 4. Global Value-Based Healthcare Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Model Estimates & Trend Analysis

5.1. by Model & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Model:

5.2.1. Accountable Care Organization

5.2.2. Patient-Centered Medical Home

5.2.3. Pay for Performance

5.2.4. Bundled Payments

Chapter 6. Market Segmentation 2: by Deployment Type Estimates & Trend Analysis

6.1. by Deployment Type & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Deployment Type:

6.2.1. Cloud

6.2.2. On-Premises

Chapter 7. Market Segmentation 3: by Platform Estimates & Trend Analysis

7.1. by Platform & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Platform:

7.2.1. Standalone

7.2.2. Integrated

Chapter 8. Market Segmentation 4: by Industry Vertical Estimates & Trend Analysis

8.1. by Industry Vertical & Market Share, 2019 & 2030

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Industry Vertical:

8.2.1. Providers (Hospitals, Clinics, Others)

8.2.2. Payers (Insurance Companies, Government, Others)

Chapter 9. Value-Based Healthcare Services Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2022-2030

9.1.2. North America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2022-2030

9.1.3. North America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2022-2030

9.1.4. North America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2022-2030

9.1.5. North America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.2. Europe

9.2.1. Europe Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2022-2030

9.2.2. Europe Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2022-2030

9.2.3. Europe Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2022-2030

9.2.4. Europe Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2022-2030

9.2.5. Europe Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.3. Asia Pacific

9.3.1. Asia Pacific Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2022-2030

9.3.2. Asia Pacific Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2022-2030

9.3.3. Asia-Pacific Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2022-2030

9.3.4. Asia-Pacific Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2022-2030

9.3.5. Asia Pacific Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.4. Latin America

9.4.1. Latin America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2022-2030

9.4.2. Latin America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2022-2030

9.4.3. Latin America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2022-2030

9.4.4. Latin America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2022-2030

9.4.5. Latin America Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2022-2030

9.5.2. Middle East & Africa Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2022-2030

9.5.3. Middle East & Africa Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2022-2030

9.5.4. Middle East & Africa Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2022-2030

9.5.5. Middle East & Africa Value-Based Healthcare Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles 

10.2.1. Deloitte Touche Tohmatsu Limited

10.2.2. Siemens Healthcare GmbH

10.2.3. Veritas Technologies LLC

10.2.4. Genpact

10.2.5. McKesson Corporation

10.2.6. NXGN Management LLC

10.2.7. 3M

10.2.8. Koninklijke Philips N.V.

10.2.9. Other Prominent Players

Segmentation of Value-Based Healthcare Services Market-

By Model-

  • Accountable Care Organization
  • Patient-Centered Medical Home
  • Pay for Performance
  • Bundled Payments

By Deployment Type-

  • Cloud
  • On-Premises

By Platform-

  • Standalone
  • Integrated

By Industry Vertical-

  • Providers (Hospitals, Clinics, Others)
  • Payers (Insurance Companies, Government, Others)

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

 

Need Complete Report ?
Our Clients